{
    "summary": "The \u201cInteragency Patent Coordination and Improvement Act of 2025\u201d establishes an interagency task force between the U.S. Patent and Trademark Office (USPTO) and the Food and Drug Administration (FDA). The task force will facilitate information sharing on patents, human drugs, and biological products. It aims to improve patent examination by providing examiners with additional information and promoting accuracy and consistency in patent applications. The bill mandates a report on the task force's activities and explores opportunities for coordination with other federal agencies.",
    "tags": [
        "Healthcare",
        "Technology regulation",
        "Federal agency action",
        "Bipartisanship",
        "Consumer protection",
        "Privacy"
    ],
    "category": "Healthcare & Public Health"
}